Navigation Links
Gloabl Harvest Initiative: Taking Down Fences To Meet Future Needs
Date:3/3/2010

March 17 symposium to unveil study aimed at ensuring global food security and sustainability.

Washington (PRWEB) -- On March 17, the Global Harvest Initiative (GHI), a not-for-profit group whose mission is to sustainably double agricultural output and improve storage and distribution to eliminate the global productivity gap, will host a symposium in Washington, D.C. to discuss the group’s science-based blueprint for meeting long-term increases in global demand for agricultural products. The blueprint, a four-chapter study, was commissioned to provide groundwork to shape the policies necessary to sustainably close the projected gap between agricultural supplies and demands.

The symposium “Closing the Gap: Examining an Alternative Future” continues the Global Harvest Initiative’s quest to develop specific policies with a global perspective and supporting those policies with changes in the global agricultural system.

As part of the symposium, The Center for Strategic and International Studies, one of the world’s preeminent international policy institutions, will conduct an expert panel discussion on the link between adequate food supplies and global security.

“This symposium brings together a prominent group of industry experts to find solutions and suggest policies for addressing one of the world’s most fundamental issues,” said Dr. William G. Lesher, executive director of the Global Harvest Initiative. “We are coming together to share ideas to achieve a common goal of sustainably feeding the world in the future.”

The authors of the study will discuss their findings:

 

    Source: PRWeb
    Copyright©2010 Vocus, Inc.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
    2. Harvest Technologies Announces Completion of Patient Enrollment in its Randomized, Controlled, Double Blind Multicenter IDE Non-Reconstructable Critical Limb Ischemia Trial
    3. UK scientists developing intelligent harvesting robot to save farms up to 100,000 a year
    4. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
    5. Scientists determine the structure of highly efficient light-harvesting molecules in green bacteria
    6. Mach One Corporation Completes Acquisition of Ceres Organic Harvest, Inc.
    7. Mach One Corporation Signs Definitive Agreement to Acquire Ceres Organic Harvest, Inc.
    8. BASF Podcast - Better Harvest in Spite of Climate Stress
    9. Carrington and Universal Harvest Sign Supply Agreement
    10. Fiber-based nanotechnology in clothing could harvest energy from physical movement
    11. Nanowire generates power by harvesting energy from the environment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... University of Manchester have generated a new star-shaped molecule made ... its kind ever created. , Known as a ... one for over a quarter of a century and the ... . , Consisting of two molecular triangles, entwined about ... molecules are tiny each triangle is 114 atoms in ...
    (Date:9/22/2014)... , Sept. 22, 2014 US demand to ... for specialty biocides is forecast to rise 3.9 percent ... terms, demand is projected to increase 1.3 percent per ... A strong rebound in construction expenditures will support demand ... coatings markets, while growth in consumer spending and manufacturing ...
    (Date:9/22/2014)... (PRWEB) September 22, 2014 Invisible ... diagnostics for the food and beverage industries, announced ... be distributed under a non-exclusive agreement by Enartis, ... services. , Enartis, an Esseco Group company headquartered ... winemakers in California and other global markets for ...
    (Date:9/22/2014)... September 22, 2014 The US ... mixed note as the Dow Jones Industrial Average finished ... at 4,579.79, down 0.30%. The S&P 500 finished the ... six out of ten sectors finished on a positive ... the day at 751.48, up 0.10%, with the index ...
    Breaking Biology Technology:US Biocides Market 2US Biocides Market 3Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 2Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5
    ... ST. LOUIS, Oct. 2 /PRNewswire-FirstCall/ -- ... ) has elected Dr. George M. Church as a Director ... Professor of Genetics at the Harvard Medical School and Director ... Dr. Church pioneered technology innovations early in the development of ...
    ... Host Conference Call-- , CALGARY, Oct. 2 /PRNewswire-FirstCall/ - ... it has reached an agreement with the U.S. Food ... (SPA) process for the design of a Phase 3 ... in patients with platinum-refractory head and neck cancers. The ...
    ... ... the recipients of the 2009 Orange County Emerging Growth Awards, recognizing companies headquartered in ... significant growth over the last 12 months and that have made a positive impact ... ...
    Cached Biology Technology:Sigma-Aldrich Elects George M. Church as Director 2Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers 2Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers 3Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers 4Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers 5Southern California Venture Network Announces Recipients of the 2009 Orange County Emerging Growth Awards 2Southern California Venture Network Announces Recipients of the 2009 Orange County Emerging Growth Awards 3Southern California Venture Network Announces Recipients of the 2009 Orange County Emerging Growth Awards 4
    (Date:9/22/2014)... -- NXT-ID, Inc. (NASDAQ: NXTD ), a ... market, issues the following corporate shareholder update following the ... Letter from the CEO : ... joined the NASDAQ to support ramping of production of ... authentication products and services. This strategic achievement positions NXT-ID to ...
    (Date:9/21/2014)... (black-eyed peas) is a fascinating example of how science ... the story of the scientist behind the research. ... the 21st Century to serve as an accessible summary ... recently published by the Crop Science Society of America, ... , Singh has devoted his life,s work to solving ...
    (Date:9/21/2014)... immune T cells may have the ability to trigger ... study led by King,s College London. Although their immune ... may still be able to mount a strong immune ... Nature Medicine . , Our immune system is made ... neutrophils which play an important role in the frontline ...
    Breaking Biology News(10 mins):NXT-ID Issues Shareholder Corporate Update 2NXT-ID Issues Shareholder Corporate Update 3NXT-ID Issues Shareholder Corporate Update 4Immune system of newborn babies is stronger than previously thought 2
    ... release is available in German . ... travel of tomorrow is meant to become quieter, cleaner and ... to accomplish just that as part of the EU ... technical aspects of air travel to the test, evaluating and ...
    ... study has highlighted the sensitivity of Australia,s species and ... ways of thinking about biodiversity conservation. ,Climate change ... natural landscapes by 2030, lead researcher, CSIRO,s Dr Michael ... be very significant and widespread. Many of the environments ...
    ... a leading software company in the clinical ... Next Generation Biobanking software platform for biomarker-based ... and academic research centers involved in biomarker-based ... effectively conduct externalized, science-driven collaborative studies. ...
    Cached Biology News:Fraunhofer supports continuation of 'Clean Sky' program 2Major changes needed to protect Australia's species and ecosystems 2BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research 2
    Takara's Mutan-Super Express Km Kit is designed to achieve site-directed mutagenesis in just one day. It is based on Oligonucleotide-directed Dual Amber (ODA) method, using the advantages of LA (Long...
    ... 4 deuterium atoms at the 9, 10, 12, ... as an internal standard for the quantification of ... produced by incubation of linoleic acid with plant ... inhibit the adhesion of tumor cells to the ...
    ... and TriEx Insect Cell Medium are recommended ... This cell/medium combination has been selected based ... protein expression levels observed specifically with baculoviruses ... that our Ready-Plaque Sf9 Cells and BacVector ...
    ...
    Biology Products: